Cargando…

Improvement of reflux symptom related quality of life after Helicobacter pylori eradication therapy

The relationship between Helicobacter pylori (H. pylori) eradication therapy and the risk of developing gastroesophageal reflux disease (GERD) is controversial. We investigated the influence of H. pylori eradication on the risk of GERD by focusing on the quality of life (QOL) and evaluating reflux s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hirata, Kenro, Suzuki, Hidekazu, Matsuzaki, Juntaro, Masaoka, Tatsuhiro, Saito, Yoshimasa, Nishizawa, Toshihiro, Iwasaki, Eisuke, Fukuhara, Seiichiro, Okada, Sawako, Hibi, Toshifumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	the Society for Free Radical Research Japan 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593136/ https://www.ncbi.nlm.nih.gov/pubmed/23524980 http://dx.doi.org/10.3164/jcbn.12-107

Ejemplares similares

Efficacy and safety of low‐dose rifabutin‐based 7‐day triple therapy as a third‐ or later‐line Helicobacter pylori eradication regimen
por: Inokuchi, Kazumi, et al.
Publicado: (2022)

Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication
por: Nishizawa, Toshihiro, et al.
Publicado: (2009)

Overexpression of miR-142-5p and miR-155 in Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Resistant to Helicobacter pylori Eradication
por: Saito, Yoshimasa, et al.
Publicado: (2012)

Correction: Overexpression of miR-142-5p and miR-155 in Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Resistant to Helicobacter pylori Eradication
por: Saito, Yoshimasa, et al.
Publicado: (2013)

Development of plasma ghrelin level as a novel marker for gastric mucosal atrophy after Helicobacter pylori eradication
por: Mori, Hideki, et al.
Publicado: (2022)

What Is the Difference Between Helicobacter pylori-Associated Dyspepsia and Functional Dyspepsia?
por: Suzuki, Hidekazu, et al.
Publicado: (2011)

Proton pump inhibitor-amoxicillin-clarithromycin versus proton pump inhibitor-amoxicillin-metronidazole as first-line Helicobacter pylori eradication therapy
por: Nishizawa, Toshihiro, et al.
Publicado: (2012)

Neutrophil-activating Protein Polymorphism of Helicobacter pylori Determines the Host Risk of Dyspepsia
por: Matsuzaki, Juntaro, et al.
Publicado: (2019)

Nordihydroguaiaretic Acid Disrupts the Antioxidant Ability of Helicobacter pylori through the Repression of SodB Activity In Vitro
por: Tsugawa, Hitoshi, et al.
Publicado: (2015)

Response to letter regarding: development of plasma ghrelin level as a novel marker for gastric mucosal atrophy after Helicobacter pylori eradication
por: Mori, Hideki, et al.
Publicado: (2022)

Sitafloxacin for Third-Line Helicobacter pylori Eradication: A Systematic Review
por: Nishizawa, Toshihiro, et al.
Publicado: (2021)

H. pylori-Eradication Therapy Increases RUNX3 Expression in the Glandular Epithelial Cells in Enlarged-Fold Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2010)

Helicobacter pylori eradication improved the Kyoto classification score on endoscopy
por: Toyoshima, Osamu, et al.
Publicado: (2020)

Helicobacter pylori and Gastric Mucosa-associated Lymphoid Tissue (MALT) Lymphoma: Updated Review of Clinical Outcomes and the Molecular Pathogenesis
por: Suzuki, Hidekazu, et al.
Publicado: (2009)

The relationship between Helicobacter pylori infection and reflux esophagitis and the long-term effects of eradication of Helicobacter pylori on reflux esophagitis
por: Hojo, Mariko, et al.
Publicado: (2021)

Current status of first- and second-line Helicobacter pylori eradication therapy in the metropolitan area: a multicenter study with a large number of patients
por: Mori, Hideki, et al.
Publicado: (2019)

Mechanisms of Helicobacter pylori antibiotic resistance and molecular testing
por: Nishizawa, Toshihiro, et al.
Publicado: (2014)

Gastric Epithelial Cell Modality and Proton Pump Inhibitor
por: Masaoka, Tatsuhiro, et al.
Publicado: (2008)

Characteristics of gastric cancer detected within 1 year after successful eradication of Helicobacter pylori
por: Nishizawa, Toshihiro, et al.
Publicado: (2016)

Helicobacter pylori: present status and future prospects in Japan
por: Suzuki, Hidekazu, et al.
Publicado: (2007)

Effects of patient age and choice of antisecretory agent on success of eradication therapy for Helicobacter pylori infection
por: Nishizawa, Toshihiro, et al.
Publicado: (2017)

Ghrelin and oxidative stress in gastrointestinal tract
por: Suzuki, Hidekazu, et al.
Publicado: (2011)

Endoscopic Reflux Esophagitis and Reflux-Related Symptoms after Helicobacter pylori Eradication Therapy: Meta-Analysis
por: Sugimoto, Mitsushige, et al.
Publicado: (2020)

Risk of Reflux-Related Symptoms and Reflux Esophagitis after Helicobacter pylori Eradication Treatment in the Japanese Population
por: Sugimoto, Mitsushige, et al.
Publicado: (2021)

Gastric Carcinogenesis and Underlying Molecular Mechanisms: Helicobacter pylori and Novel Targeted Therapy
por: Nishizawa, Toshihiro, et al.
Publicado: (2015)

Superiority of urgent vs early endoscopic hemostasis in patients with upper gastrointestinal bleeding with high-risk stigmata
por: Horibe, Masayasu, et al.
Publicado: (2021)

Does Bile Reflux Influence the Progression of Barrett's Esophagus to Adenocarcinoma? (Gastroenterology 2013;145:1300-1311)
por: Masaoka, Tatsuhiro, et al.
Publicado: (2014)

Reflux esophagitis triggered after Helicobacter pylori eradication: a noteworthy demerit of eradication therapy among the Japanese?
por: Iijima, Katsunori, et al.
Publicado: (2015)

Influence of regular exercise on gastric emptying in healthy men: a pilot study
por: Matsuzaki, Juntaro, et al.
Publicado: (2016)

Characteristics and predictors of gastric cancer after Helicobacter pylori eradication
por: Shichijo, Satoki, et al.
Publicado: (2018)

Helicobacter pylori: Eradication or Preservation
por: Sachs, George, et al.
Publicado: (2012)

Patients with established gastro-esophageal reflux disease might benefit from Helicobacter pylori eradication
por: Moschos, John M., et al.
Publicado: (2014)

Does Helicobacter pylori eradication or proton pump inhibitor use benefit gastroesophageal reflux disease?
por: Sakin, Yusuf Serdar, et al.
Publicado: (2015)

Effect of Helicobacter pylori Eradication on the Development of Reflux Esophagitis and Gastroesophageal Reflux Symptoms: A Nationwide Multi-Center Prospective Study
por: Kim, Nayoung, et al.
Publicado: (2011)

Efficacy of Solifenacin on Irritable Bowel Syndrome With Diarrhea: Open-label Prospective Pilot Trial
por: Fukushima, Yasushi, et al.
Publicado: (2012)

Helicobacter pylori and gastroesophageal reflux disease
por: Grande, Michele, et al.
Publicado: (2008)

Effect of Helicobacter pylori Eradication on Reflux Esophagitis Therapy: A Multi-center Randomized Control Study
por: Xue, Yan, et al.
Publicado: (2015)

Effects of Helicobacter pylori eradication on esophageal motility, esophageal acid exposure, and gastroesophageal reflux disease symptoms
por: Zhao, Tong, et al.
Publicado: (2023)

Kyoto classification in patients who developed multiple gastric carcinomas after Helicobacter pylori eradication
por: Sakitani, Kosuke, et al.
Publicado: (2020)

Newer agents for Helicobacter pylori eradication
por: Fiorini, Giulia, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_i9fr96p5qqibtsf51ji6v91jhs